Huang, Y., Kwan, M. L., Heckbert, S. R., Smith, N. L., Othus, M., Laurent, C. A., Roh, J. M., Rillamas-Sun, E., Lee, V. S., Kolevska, T., Cheng, R. K., Irribarren, C., Nguyen-Huynh, M., Hershman, D. L., Kushi, L. H., & Greenlee, H. (2025). Duration of aromatase inhibitor use and long-term cardiovascular risk in breast cancer survivors. JNCI Cancer Spectrum. https://doi.org/10.1093/jncics/pkaf009

Henry, N. L., Unger, J. M., Vaidya, R., Darke, A. K., Skaar, T. C., Fisch, M. J., & Hershman, D. L. (2024). Active symptom monitoring for premenopausal women with breast cancer initiating adjuvant endocrine therapy: Protocol for the SWOG S2010 randomized controlled efficacy trial. Contemporary Clinical Trials, 147, 107712. https://doi.org/10.1016/j.cct.2024.107712

Henry, N. L., Unger, J. M., Till, C., Crew, K. D., Fisch, M. J., & Hershman, D. L. (2021). Predictors of Pain Reduction in Trials of Interventions for Aromatase Inhibitor–Associated Musculoskeletal Symptoms. JNCI Cancer Spectrum, 5(6). https://doi.org/10.1093/jncics/pkab087